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1. Introduction
The ability of microorganisms to adapt to different physico-
chemical environments is a key characteristic of life.[1] This 
fundamental process can be harnessed to intentionally trigger 
living systems to gain novel traits or to enhance their inherited 
characteristics in a process termed adaptive laboratory evolu-
tion (ALE).[2,3] ALE is an essential methodology to investigate 
fundamental questions ranging from the evolution of life and 
Microfluidic devices can mimic naturally occurring microenvironments and 
create microbial population heterogeneities ranging from planktonic cells to 
biofilm states. The exposure of such populations to spatially organized stress 
gradients can promote their adaptation into complex phenotypes, which are 
otherwise difficult to achieve with conventional experimental setups. Here 
a microfluidic chip that employs precise chemical gradients in consecutive 
microcompartments to perform microbial adaptive laboratory evolution 
(ALE), a key tool to study evolution in fundamental and applied contexts 
is described. In the chip developed here, microbial cells can be exposed to 
a defined profile of stressors such as antibiotics. By modulating this pro-
file, stress adaptation in the chip through resistance or persistence can be 
specifically controlled. Importantly, chip-based ALE leads to the discovery of 
previously unknown mutations in Escherichia coli that confer resistance to 
nalidixic acid. The microfluidic device presented here can enhance the occur-
rence of mutations employing defined micro-environmental conditions to 
generate data to better understand the parameters that influence the mecha-
nisms of antibiotic resistance.
its underlying mechanisms to the adap-
tation of microbial populations to their 
environments, such as the emergence 
of antibiotic resistance.[4–7] Especially in 
biotechnological production, ALE has 
been employed to improve yields or to 
enhance the microorganism’s tolerance 
to toxic conditions.[2,3] Although ALE has 
many applications, it is simply based on 
the general principle of biological evolu-
tion, involving two interplaying processes: 
genetic variation and selection.[4] Genetic 
mutations occur naturally during the DNA 
replication as spontaneous rare events,[4,8] 
but their occurrence can be enhanced in 
response to stress or external factors.[4,8] 
Some mutations enable the microor-
ganism to grow better under normally 
inhibitory conditions. Selection of such 
advantageous traits is the goal of ALE.
Technically, the simplest ALE setup uti-
lizes conventional cultivation equipment 
such as shake flasks for serially passaging 
of batch cultures for prolonged time, with a stepwise increase 
of selection pressure.[9] Such methods are very laborious and 
require culture manipulation on a daily basis for up to months. 
Therefore, liquid-handling robots,[10] conventional bioreac-
tors,[11] as well as tailor-made cultivation devices[12,13] have been 
employed to automate and reduce the hands-on time of ALE. 
Nevertheless, these techniques usually require expensive equip-
ment and specially trained personnel, which hinders their 
widespread use in common microbiological laboratories.
It is relevant that the ALE techniques mentioned above mainly 
involve vigorous mixing of planktonic bacteria in a defined chem-
ical environment, and therefore pay less attention to the role of 
other natural adaptive mechanisms. For example, microenvi-
ronments rich in spatial physico-chemical gradients are omni-
present in nature and often characterize the habitat of planktonic 
and biofilm populations.[14,15] Since phenotypic hetero geneity as 
well as the formation of biofilm communities can also allow cells 
to adopt a sustainable lifestyle without genetic modification, the 
resulting stress persistence needs to be taken into account when 
optimizing ALE. To address this issue, advanced microtechnical 
solutions for ALE should also include 3D microenvironments 
as protected habitats that can favor population hetero geneity. 
Recent studies have emphasized the importance of concen-
tration gradients and hetero genic microenvironments on the 
composition and adaptability of bacterial populations.[16–19] The 
integration of spatial chemical gradients[18] within meso and 
macroscopic ALE systems, however, is technically challenging.
© 2021 The Authors. Small published by Wiley-VCH GmbH. This is an 
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Miniaturized fluidic chip systems are gaining a steadily 
growing impact on the analysis of microbial systems,[20–24] 
and microfluidic devices with integrated spatial concentration 
gradients have been successfully used for toxicity testing[25,26] 
and directed evolution.[27,28] However, the ability to generate 
spatially defined gradients of stressors is still limited. Addition-
ally, screening of the adapted mutants in these systems is not 
well optimized for robust, long-term ALE experiments, which 
often lead to clogging of the chip due to accumulated biomass 
and obstruction of the sensitive gradient-generating flow sys-
tems. Due to these obstacles, the majority of microbial studies 
in microfluidic gradients usually do not encompasses cultiva-
tions for more than 2 days[27,29–32] and may not be able to dis-
cover adaptations that often manifest themselves only after 
prolonged cultivation.[7,33] To overcome these limitations and 
to enable long-term ALE experiments with efficient screening 
under unfavorable high stress conditions, we here describe a 
novel, robust, and user-friendly miniaturized ALE chip design 
that employs adjustable spatial stress profiles and an in-flow 
gradient while at the same time enabling efficient on-chip 
screening of the complete cell population.
2. Results and Discussion
2.1. Design Strategy
Commonly used microfluidic gradient structures for micro-
bial studies can be classified according to where the cultivation 
chamber containing the gradient is located in relation to the 
flow. Therefore, one has to distinguish between ex-flow[17,30,34] 
(Figure 1a) and in-flow[29,35,36] (Figure 1b) gradients. In both sys-
tems the gradient is usually oriented horizontally to the flow 
direction (Figure  1a,b), thus screening and enrichment of the 
adapted mutants depends on cells moving from the low stress 
areas (Figure 1a,b, X) toward areas of high stressor concentra-
tion (Figure  1a,b, Y) either actively as motile cells or passively 
due to the increase in biomass. Bacterial motility is indeed con-
trolled by chemotactic decisions that usually will avoid high-
stress environments,[28] thus impeding effective selection in 
ALE. To solve this problem, many systems require special nutri-
ents arrangements, such as low nutrients at low stress areas, 
and high nutrients at high stress areas, in order to attract motile 
cells via chemotaxis for screening at high stress, which can lead 
to a more complex and potentially error-prone design.[28,37] For 
the in-flow approach (Figure 1b), the active cell movement will 
be additionally deflected by the orthogonal flow forces of the 
medium in the chip. Therefore, in these gradient approaches 
adapted cells potentially never reach the high-stress areas of the 
chip where the selection can occur (Figure 1a,b, Y).[28]
To address this shortcoming, the current work uses an in-
flow gradient along the flow direction (Figure  1c). In such a 
setup, flow forces carry the cells toward the up-gradient regions 
containing high concentrations of the stressor (Figure 1c, Y). 
This allows the use of non-motile strains and counteracts a 
possible evasion of the high stress areas by chemotaxis. In 
order to realize such an in-flow gradient, the novel miniatur-
ized ALE chip was designed based on a stepwise cumulative 
increase in concentration of stressors throughout connected 
compartments (Figure  2a). A hypothetical stress gradient as 
shown in Figure  2a is achieved by injecting the stressor-free 
medium into the main inlet while the five side inlets serve 
to establish a customizable spatial concentration gradient 
in the subsequent wells by supplying medium with defined 
stressor concentration and flow rates. The chip comprises six 
wells (for the dimensions see Figure S1a, Supporting Informa-
tion), designated as 0, I, II, III, IV, and V, which are connected 
through passive diffusion mixers (Figure  2b). When the gra-
dient is stabilized under constant flow, a bacterial inoculum 
can be seeded into the stressor-free well (0) and all resulting 
progeny cells can be flushed out continuously by flow forces 
toward the higher stressor levels in the downstream wells I–V. 
As a result, all cells produced by the biomass in the wells are 
exposed to the higher stress levels in all subsequent wells. 
Since only clones with higher fitness will survive, a new 
population can reside in the wells and grow at the respective 
stressor level whereas all other clones are washed-out to the 
waste. Furthermore, the 3D architecture of the wells features a 
microenvironment with reduced flow velocities at the bottom 
of the wells to mimic natural niches and enabling the growth 
Figure 1. Concepts of gradient generation. The gradient chamber in which cultivation takes place can be located either outside or inside the flow, 
dubbed as a) ex-flow and b,c) in-flow gradients, respectively. In commonly used ex- and in-flow (a,b) systems, the direction of the gradient and screening 
are oriented horizontally to the flow direction, while in the herein applied design (c), they are vertical to the flow direction. While in areas with low 
stressor concentration (blue, minimum = X) the cells can grow well, in areas with high stress (red, maximum = Y) the screening and enrichment of 
mutants with increased fitness takes place.
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of biofilms and cell aggregates along with the individual cells 
on top (Figure 2c).
2.2. Testing and Validation
The constant improvement of microfabrication has led to very 
sophisticated microfluidic structures, enabling new ways to 
cultivate, manipulate, and investigate microorganisms down 
to the single cell level under defined growth conditions.[38–41] 
However, such sophisticated systems typically involve complex 
structures that are difficult to fabricate or operate by non-expert 
users. Here, we aimed for a simple fabrication method that 
requires a minimum of microfabrication knowledge and equip-
ment, resulting in a disposable chip. Therefore, we first manu-
factured a negative structure of the microfluidic chip by milling 
of a poly(methyl methacrylate) (PMMA) mold, which was then 
casted as a positive structure using the biocompatible and gas-
permeable material polydimethylsiloxane (PDMS) (Figure 2b).
Figure S2, Supporting Information, shows a typical flow 
setup demonstrating that more than one chip can be run in 
parallel. In order to validate the chip’s ability to create gradients 
as designed, the blue dye xylene cyanol FF (XC, 538.61 g mol−1) 
was utilized to generate a gradient. The XC gradient in the 
chip was initially simulated using the COMSOL Multiphysics 
 software considering 10  µL min−1 main-flow of water in the 
main inlet and 2  µL min−1 co-flows with 40  mg L−1 of XC in 
each of the five side inlets (Figure 3a). The same concentrations 
and flow rates were also experimentally verified employing 
the full setup comprising the chip and the respective flows 
(Figure 3b). Both theoretical and experimental analyses showed 
an identical, uniform XC concentration profile starting from 
0 mg L−1 in the first well (0) to 20 mg L−1 in the last well (V).
For additional confirmation, all six wells were sampled 
and analyzed spectrophotometrically for their XC concen-
trations, which confirmed the match between theory and 
experiment (Figure  3c). Additionally, simulations using other 
small-molecule substances with different molecular weights, 
namely ethanol (46.1  g mol−1) and the antibiotic ciprofloxacin 
(331.3  g mol−1), confirmed that homogenous gradients inside 
the chip were formed in all cases (Figure S3, Supporting 
Information).
We then validated the chip’s utility for culturing cells and the 
effects of the chemical gradient on cell survival. To this end, the 
Figure 2. Gradient generation inside the chip and 3D architecture. a) The chemical gradient is cumulatively formed inside the connected wells by 
gradual supplementation of the main-flow via stepwise addition of defined stressor concentrations at defined flow rates. b) The final chip is made of 
PDMS and designed to host microbial cultures in wells (c), which can build mixed populations ranging from individual cells, to cell aggregates and 
biofilms. Well dimensions: d = 5 mm, h = 1.2 mm, v = 23.5 µL. The inset illustrates that wells are 0.7 mm deeper than the channels (height 0.5 mm). 
For technical details, see Figure S1a, Supporting Information, for the whole chip and Figure S1b, Supporting Information, for the wells.
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model bacterium Escherichia coli K12 was cultured in conven-
tional Luria–Bertani (LB) medium, which was used as the source 
for nutrients as well as a solvent for the stressor substances. In 
order to establish a proof of concept, an EtOH gradient in LB 
ranging from 0% to 7% v/v was generated. In this context, the 
design of our system also allows the use of two sequentially 
connected chips to ensure a fine resolution of the gradient 
(Figure S4, Supporting Information). We found that the bacterial 
growth was impaired at 5.3% EtOH v/v (Figure S4a, Supporting 
Information, well VI) which is in line with the inhibitory con-
centration of 5% EtOH v/v, as determined by standard micro-
titer plate cultivation (Figure S4b, Supporting Information). In 
this way, precise gradients of chemical stressors can be gener-
ated inside the chip, which can be used as a necessary selection 
pressure for ALE. Notably, air bubbles occasionally accumulated 
in the wells, but no significant effect on gradient generation was 
observed, as evidenced by growth inhibition in the corresponding 
inhibition wells (Figure S4, Supporting Information). This can 
be attributed to the design of the chip, where the gradient gener-
ation is realized via supply of different liquids through the main 
media and stressors inlets, which are controlled precisely, con-
tinuously, and independently by external pumps, and thus are 
not affected by internal air bubbles in the chip.
Apart from a pronounced stressor concentration in the 
wells, it is important that the chip design allows potential 
mutants to have sufficient residence time in the wells to allow 
for their growth and selection. The chip is operated at an 
overall flow rate of 20 µL min−1 to ensure sufficient nutrient 
supply to the cells. If only single, planktonic cells were con-
sidered, which are pumped through the channel parts of 
the chip (≈240  µL volume), a theoretical residence time of 
12 min would result. At this flow rate, the typical residence 
time inside a well is 1.3 ± 0.8 min as determined from experi-
ments with E. coli being pumped through wells overgrown 
with biomass (for details see Figure S5, Supporting Informa-
tion). Hence, total residence times for cells pumped through 
the chip are substantially lower than the typical E. coli division 
time of 20 min.[42] This means that all planktonic cells would 
be quickly flushed out of the chip before they can divide, evo-
lutionary adaptation is unlikely. Therefore, the 3D architec-
ture of the chip was designed in such a way that the bottom 
of the wells is 0.7 mm below the medium flow from the flow 
channel (see Figure  2c and Figure S1a, Supporting Informa-
tion), so that the cells can descend into these lower parts of 
the well (Figure S1b, Supporting Information) and grow 
there for longer periods of time as planktonic cells or as non-
planktonic cell aggregates. The functionality of this concept is 
clearly confirmed by the occurrence of turbidity in the wells, 
≈2 h after inoculation, due to growing biomass (Video S1, 
Supporting Information). After about 10 h, a quasi-static bio-
mass has established itself in these microenvironments and 
the residence time of the cells in this biofilm state is variable 
depending on their position within the well.
In this regard, it is important to note that initial growth 
started in specific regions of the wells and not in the chan-
nels (Figure 4a). This phenomenon can be explained by taking 
into account simulations of the flow velocities within the chip 
(Figure 4b). Although the chips are operated at a constant, high 
flow rate of 20 µL min−1, the simulation revealed an inhomoge-
neous distribution of the velocity in the wells. Flow velocities 
of up to 25 × 10−4 m s−1 (148 mm min−1) and 1.8 × 10−4 m s−1 
(7 mm min−1), respectively, can be observed in the channels and 
defined areas of the 3D wells (Figure  4b, white arrow), which 
should lead to an extensive washout of cells. However, near the 
walls and the bottom of the wells flow velocities of less than 
0.12 × 10−4 m s−1 (0.7 mm min−1) occur (Figure 4b, black arrow), 
enabling cells to remain in the wells for prolonged times (cells 
will take at least 13  min to traverse a well near the bottom). 
Notably, over time the profiles of the biomass grown in the 
chip typically showed a pattern that corresponded to these flow 
velocity profiles (Figure 4c). It was also observed that high den-
sities of biomass are usually accumulated in areas with low flow 
velocities (Figure  4b,c, black arrow) while less dense biomass 
was formed in high velocity areas in the wells (Figure  4b,c, 
white arrow). These observations confirm that even when using 
high flows rates to ensure excess of nutrients, the biomass 
residing in the wells is continuously producing new cells to be 
transported by flow to the adjacent wells.
The design of the individual wells (see Figure  2c) ena-
bles the formation of complex microbial populations in the 
resulting microenvironments. Individual cells and cell aggre-
gates can detach from the population and are thus moved to 
the subsequent compartments due to the flow. In contrast, 
cells in biofilm states reside within the wells for prolonged 
time. The occurrence of such diverse microbial lifestyles can 
be examined by optical and microscopic analyses. In order 
to get an assessment of the resulting population composi-
tion inside the chip, E. coli was cultivated within the chip for 
8 days (Figure  5a(I)). For subsequent analysis, the biomass 
Figure 3. Chemical gradient formation and validation on chip. The chip’s 
functionality for gradient formation was validated by a) simulation and b) 
experiment using the blue dye xylene cyanol (XC) with the same param-
eters. c) The concentrations verified experimentally by spectroscopic 
determination of samples from the individual wells match well with the 
concentrations derived from simulation. Error bars are SD of five inde-
pendent determinations in simulated and duplicate measurements in 
experimental gradients.
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was flushed from the chip using air. This material, dubbed 
biofilm-like (BFL) culture, was found to be of high density, 
opaque transparency and contained viscous agglomerates of 
biomass (Figure 5b, Inset). Such BFL material[43,44] is formed 
in the wells where it is shielded from the flow shear forces. 
It consists of a mix of individual cells and cell aggregates in 
extracellular polymeric substances[45] leading to biofilm-like 
structures (Figure S6, Supporting Information). The micro-
scopic analysis of the cell populations within the chip clearly 
indicated that the chip enabled growth of E. coli as individual 
cells as well as in biofilm and BFL aggregates and that the 
three forms have a distinctly different morphological appear-
ance (Figure S6, Supporting Information). For quantification, 
the isolated BFL material as well as the remaining surface-
attached biofilm (BF, Figure 5a(II)) were stained with crystal 
violet (CV).[46] The residing biofilm was then removed from 
the chip using 33% acetic acid (Figure  5a(III)) and both 
BFL and BF samples were quantified by spectrophotometry 
(Figure 5c). This relative comparison showed that the typical 
residing BF fraction on average accounts for about 20 ± 10% 
of the total biomass in the chip. These results confirm that 
the chip enables the growth of complex microbial populations 
under defined stressor concentrations as intended.
Figure 4. Influence of the flow profile on biomass growth pattern. a) Upon inoculation, the bacterial growth is always initiated in the wells (marked 
yellow), not in the channels. b) This corresponds well with the simulation of velocity profiles inside the chip using the COMSOL Multiphysics software, 
demonstrating non-homogeneous velocities in the wells, with high and low velocities indicated by white and black arrows, respectively. Please note 
that the flow velocities inside the wells are more than a factor of 25 lower than in the channels. c) The E. coli biomass distribution can be visualized 
by imaging and represented in 3D, indicating that the intensity patterns generally follow the flow velocity profile with high biomass intensities being 
present in low velocity areas (black arrow), and low biomass in high velocity areas (white arrow). The biomass was measured by trans-UV imaging and 
the intensity maps were calculated using the ImageJ software.
Figure 5. Composition of E. coli cultures in the chip. E. coli cells were 
cultivated in chips for 8 days. a) The mature culture inside the chip com-
prised a biofilm-like (BFL) material (I) which was flushed out using air, 
collected and quantified using crystal violet (CV) staining. A biofilm (BF) 
biomass remained attached to the chip surface (II) and could also be 
stained by CV. The BF was subsequently removed using 33% v/v acetic 
acid leaving the chip empty (III). b) The total BF and BFL biomass were 
directly compared using the colorimetric CV assay, which correlates bio-
mass to the absorption at 585 nm. Inset: The BFL material removed from 
the chip in (I) is intensely opaque and viscous. For a microscopic analysis 
see Figure S6, Supporting Information. Error bars are the standard devia-
tion (SD) of four samples derived from two independent chip replicas.
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2.3. ALE on Chip
The spread of antibiotic resistance is a threatening global 
issue.[19,27] One common mechanism bacteria use to quickly 
evolve resistance is by mutating the DNA encoding for the anti-
biotic target protein.[19,47] Since such processes represent a per-
fect test case for ALE, we employed our chip to evolve resistance 
to the antibiotics rifampicin (Rif) in E. coli. In order to establish 
gradients, which can efficiently suppress growth of wild type 
(WT) cells at the higher concentration level, we first determined 
the concentration-dependent effect of Rif on the growth of E. coli 
in LB using conventional microtiter plate cultivation (Figure S7, 
Supporting Information). Within the tested range, Rif could 
affect E. coli growth starting at 2.5 µg mL−1. Significant inhibition 
was observed at 16 µg mL−1 and higher, when a large inoculum 
size of OD600 0.2 was used to replicate the dense starting popula-
tion to be used in the chip experiments. We then applied Rif in 
a concentration range of 0–100 µg mL−1 to the chip. Importantly, 
due to the novel design of the chip, different predefined concen-
trations can be generated in the connected wells to investigate 
whether population evolvability can be influenced by the spatial 
gradient profile. Therefore, we defined two different concentra-
tion profiles in two independent chips (Figure 6a).
In the first case (chip-A, Figure  6) we replicated the con-
centrations from the microtiter plate experiment to generate a 
smooth gradient ranging from no Rif (well 0) to 100  µg mL−1 
Rif (well V). In the second case (chip-B, Figure 6), a steep jump 
from no Rif in well 0 directly to 100  µg mL−1 Rif in all other 
wells (I–V) was generated. Both chips were inoculated in the 
Rif-free well 0 using an identical E. coli K12 monoclonal  culture 
and then incubated under continuous flow for 6 days to reach 
the full growth saturation and to verify the chip’s ability to per-
form long-term cultivation (Figure S8a,c and Video S2, Sup-
porting Information). It should be noted that, although the 
chips were heavily covered with biomass at later stages of the 
experiment, no clogging of individual wells was observed, even 
for long cultivation periods of up to 14 days (data not shown). 
In both chips, growth could be visually observed in the Rif-free 
wells (0) ≈2 h after inoculation (see Video S2, Supporting Infor-
mation) and substantial growth at the end of the experiment in 
the wells containing 100 µg mL−1 Rif in both chips, clearly indi-
cated that the cells had adapted to the presence of rifampicin 
(Figure 6b). Interestingly, the occurrence of observable growth 
in the consecutive wells was correlated with the steepness of 
the gradient (Video S2 and Figure S9, Supporting Informa-
tion). In chip-A (smooth gradient) growth up to until well III 
(16 µg mL−1 Rif) was already observed after 3.4 h and the cells 
needed 6.4 h in total to establish growth in well V (100 µg mL−1 
Rif). At the same concentration in chip-B (well I) growth was 
observed after approximately the same time, however it took 
in total more than 16 h to settle in all wells. This nearly par-
allel growth initiation at 100  µg mL−1 Rif in both setups sug-
gested that the gradient profile had no significant impact on 
the evolution. However, subsequent studies on the antibiotic 
resistance evolved in the two chips showed that this conclusion 
was not correct. We isolated cells from the individual wells and 
tested whether they could grow on selective LB agar plates with 
100 µg mL−1 Rif (Figure 6c; Figure S8b,d, Supporting Informa-
tion). Surprisingly, we found that cells isolated from the smooth 
gradient profile (chip-A) showed no rifampicin resistant clones 
Figure 6. Evolution of rifampicin (Rif) resistance in the chip reveals the critical influence of the gradient profile on E. coli adaptability. a) Two con-
centration profiles were set as a smooth (chip-A) or steep (chip-B) gradients that reach the same final concentration of 100 µg mL−1 Rif. b) While 
both gradients showed identical endpoint growth in the chip after 6 days, c) testing of the adapted populations on selective Rif+ agar plates showed 
the successful evolution of Rif resistance only for cells obtained from the steep gradient chip (plate H). Note that controls plated on the Rif- plates 
(Figure 6c and Figure S8b, Supporting Information) indicate the presence of living E. coli cells in all samples. For daily images and all well data see 
Figure S8, Supporting Information.
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on the selective Rif+ plates (Figure 6c; Figure S8b, Supporting 
Information). In contrast, cells derived from the steep gra-
dient chip-B indeed indicated the evolution of rifampicin 
resistant clones (Figure  6c well III in chip-B and Figure S8d, 
Supporting Information). Fivefold repetition of these experi-
ments employing smooth/steep Rif gradient chips confirmed 
these results. Resistant clones were obtained from steep gra-
dient cultivation (chip-B) in four trials resulting in hundreds 
of clones per plate (see plate well III in chip-B, in Figure  6c 
and Figure S8d, Supporting Information), indicating a high 
incidence of mutations. The smooth gradient (chip-A), how-
ever, resulted in resistant clones in only two trials and also in a 
much lower occurrence of individual resistant clones.
This highly interesting result can be explained by the effects 
of non-killing doses of antibiotics, which are known to induce 
bacterial stress responses.[48] In the smooth gradient chip, the 
bacterial cells experience sub-inhibitory Rif concentrations 
in the initial wells, I and II (for rifampicin concentration-
dependent growth see Figure S7, Supporting Information). 
Under these conditions, either the generation of persister cells 
as well as the formation of a biofilm can be triggered, which can 
shield the population against antibiotics and thus lead to collab-
orative protection, also known as persistence.[49] Or else, stress-
induced mutagenesis can occur, which is a hyper mutagenesis 
mechanism that can result in true genetic resistance.[50] While 
“persistence” reflects a transient and restricted phenotypic fit-
ness under certain environmental conditions, “resistance”, on 
the other hand, is a fixed genotypic adaptation.
Our results indicate that the smooth gradient chip favors 
the generation of a population of persistent cells, whereas 
the steep gradient leads to true genetic variation. Triggered 
by the sub-inhibitory concentration in the initial wells, the 
phenotypic adaptations might then proliferate to tolerate the 
more toxic environments in the subsequent wells. However, 
it has been reported that such persistent cells can eventually 
evolve into resistant cells.[47] This scenario in fact explains 
the rare occurrence of resistant cells observed for the smooth 
gradient. In contrast, in the steep gradient mode of chip-B, 
the cells are immediately exposed to Rif levels beyond the 
inhibitory concentration. The latter situation is known as 
adapt-or-die,[28] therefore, only cells that develop appropriate 
mutations for Rif resistance will survive, migrate to higher 
wells, and propagate on selective Rif+ plates. For a graphical 
representation of the two processes, see also, Figure S10, Sup-
porting Information.
The importance of the steepness of the gradient is further 
highlighted, when taking into consideration a different system 
for adaptation to the antibiotic ciprofloxacin reported by Zhang 
et al.[27] In their microarray chip experiments, motile cells were 
moving toward the areas of highest concentration of ciproflox-
acin (so called Goldilocks). Resistant E. coli mutants emerged 
in only 5 h after inoculation with 106 cells.[27] The authors argue 
that since WT cells cannot survive under the conditions at the 
Goldilocks, they are only present at low population densities 
and posing no competition to the de novo resistant mutants, 
which can fix rapidly because of their increased fitness to high 
antibiotic concentrations.[27,51] Although both systems cannot be 
directly compared, our results presented here suggest that the 
WT cell number might not be the key factor in this process. 
While we used a comparable initial inoculum in well 0 
(≈2.4 × 106  cells), the accumulation of biomass leads to popu-
lation sizes of >107  cells per well, as determined by counting 
colonies formed by samples from individual wells. This biomass 
in one well offer a continuous supply of cells to the subsequent 
wells (see chip-B Video S2, Supporting Information), resulting 
in a large number of WT cells to potentially compete with the 
de novo resistant mutants in the selective wells. Still in the 
steep gradient, we found a high number of mutants (Figure 6c, 
Rif+ in chip-B), correlating with the fact that the Goldilocks 
structures are also the points of the steepest increase in con-
centration in the earlier study.[27] This suggests, that the steep-
ness of the stress gradient is the decisive factor leading to rapid 
adaptation via stress-induced mutagenesis as also suggested by 
Frisch and Rosenberg,[51] and Zhang et al.[37]
Having successfully established ALE to confer Rif resistance 
in E. coli, we investigated whether the chip can as well be used 
to generate resistance to other antibiotics with different inhibi-
tory mechanisms. Rifampicin primarily binds to the bacterial 
DNA-dependent RNA polymerase (RNAP) and impairs the 
RNA transcription process, which can be prevented by muta-
tions in the rpoB gene coding for the RNAP β-subunit.[52] As 
a next target we chose nalidixic acid (NA), which binds to the 
bacterial DNA gyrase thereby interrupting the process of DNA 
replication.[53] In this case, resistance is conferred by muta-
tions in genes coding for the DNA gyrase (gyrAB) as well as the 
topoisomerase IV (parCE).[53]
We initially established that growth of E. coli was effec-
tively prohibited for NA concentrations greater than 4 µg mL−1 
(Figure S11a, Supporting Information). We then used a 
smooth concentration gradient (chip-A) as well as a steep gra-
dient (chip-B), both of which ranged from 0 to 40 µg mL−1 NA 
(Figure S11b, Supporting Information). Again, the cultivation 
was started by inoculation of E. coli in the NA-free well and 
continued for 6 days (Video S3, Figures S11c and S12a,c, Sup-
porting Information). Analysis was achieved by sampling and 
plating on selective LB agar plates containing 40 µg mL−1 NA. 
Similar as in the case of Rif, only the steep gradient efficiently 
produced E. coli mutants, which were capable of growing at 
inhibitory concentrations of NA. In contrast, the smooth gra-
dient yielded no such mutants (Figures S11d and S12b,d, Sup-
porting Information).
To further investigate the acquired mutations, ten randomly 
selected clones from both the Rif and NA experiments were 
cultivated in LB broth for 24 h that contained the respective 
antibiotics and the resulting optical density was determined. 
Whereas WT E. coli revealed an impaired growth, all mutants 
showed only small variations in the presence or absence of Rif 
(Figure 7a) and NA (Figure 7b), indicating their high fitness in 
the presence of antibiotic stress. To further confirm the pres-
ence of specific mutations, we analyzed the rpoB gene coding 
for the RNAP β-subunit in case of Rif, and the gyrA and gyrB 
genes encoding for the DNA gyrase as well as the parC and 
parE genes for the topoisomerase IV in case of NA. These 
genetic analyses were conducted for five of the adapted mutants 
randomly selected from both antibiotic adaptations and com-
pared to the WT strain. As expected, relevant mutations were 
found in the respective genes of all mutants (Figure 7c), while 
mutations were absent in the parental WT strain.
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All Rif-resistance conferring mutations identified (D516N, 
H526Y and R529H) as well as two NA-resistance muta-
tions (A67S and D82G) had already been reported in earlier 
studies[54–57] and can also be mapped to the respective protein 
structure (Figure S13, Supporting Information and Figure 7d,e). 
However, to the best of our knowledge, the two mutations iden-
tified in gyrB have not previously been described to confer 
resistance to NA in E. coli. Based on the recently published full 
structure of the complete E. coli gyrase,[58] we could locate the 
position of our newly identified mutations P747S and Q749P in 
a loop of the gyrase B subunit, which is facing a neighboring 
gyrase A subunit (Figure  7f). The newly identified mutations 
will help to enhance our understanding of the  structural basis 
for nalidixic acid resistance. Overall, these results clearly 
emphasize the utility of our chip to trigger diverse, and poten-
tially previously unknown mutations that cause antibiotic resist-
ance. In order to elucidate how the occurrence of mutations 
within the bacterial population is influenced within the chip, 
further investigations should focus on the individual contribu-
tion of the spatial organization.[59,60] How the different micro-
bial life forms affect adaptation, especially with respect to yet 
underexplored lifestyles beyond planktonic and typical surface-
attached biofilm states, such as the BFL material, also requires 
further analysis.[61] Novel microfluidic devices in combination 
with appropriate analytical methods can enable the analysis of 
such mixed populations and co-microbial cultures and improve 
Figure 7. Phenotypic and genotypic validation of E. coli mutants adapted to Rif and NA. While the growth of the wild-type E. coli for 24 h is impaired 
by the presence of Rif or NA, randomly selected mutants from the adaptation experiments to a) Rif and b) NA can grow in selective liquid cultures 
supplemented with 100 µg mL−1 of Rif and 40 µg mL−1 of NA, respectively. c) Point mutations identified in clones of the adapted E. coli mutants in the 
resistance-conferring genes: rpoB for Rif and gyrA and gyrB for NA. nt. = position of nucleotide in the gene in relation to the E. coli K12 genome (Gen-
Bank: U00096.3). aa. = position of amino acid in the corresponding protein sequence. d) Molecular structure of the E. coli gyrase (PDB ID 6RKW).[58] 
Two subunits of GyrA (in gray) and two subunits GyrB (in green) form a complex with a DNA molecule. The resistance conferring mutations in the core 
of the DNA-enzyme complex (red circle) are shown as the wild-type amino acids depicted in red. e) Two NA-resistance mutations (A67S and D82G) 
are located at the interface of the DNA and two subunits of gyrase A (dark gray). f) Two previously unknown mutations (P747S and Q749P) are located 
in a loop of gyrase B (green) facing the surface of the neighboring subunit of gyrase A (dark gray, atoms depicted as spheres). All protein structures 
where generated based on the available crystal structure data (PDB ID 6RKW)[58] using the software PyMOL.
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the understanding of the molecular basis for their behavior and 
adaptation.[41]
3. Conclusion
We here described a novel microfluidic chip that generates 
tunable and stable spatial concentration gradients in con-
nected compartments, to enable miniaturized ALE procedures. 
The chip’s capability to stably maintain chemical gradients in 
serial and parallel setups was employed to rapidly evolve E. coil 
resistance to the antibiotics rifampicin and nalidixic acid. The 
chips’ design enables the application of different concentration 
gradients, which revealed the critical influence of the gradient 
profile on the adaptability of E. coli based on either phenotypic 
persistence or genetic resistance. Importantly, the microen-
vironments within the chip create mixed populations ranging 
from individual cells over biofilm-like cell aggregates to quasi-
static biofilms. The combination of these lifestyles within the 
chip recreates natural conditions better than it is possible with 
existing ALE methods, which employ planktonic cell cultures. 
This feature is particularly relevant considering the importance 
of such mixed populations for evolution.[16,62] In addition to 
applications in basic research on complex evolutionary mecha-
nisms, our chip design can also be used for investigations in 
the biomedical context, such as to understand the development 
of antibiotic as well as cancer drug resistance.[63] In combina-
tion with automated liquid handling, machine-assisted cul-
turing and analysis[24] as well as high-throughput genomics 
and transcriptomics,[64] the here described ALE chip could 
also enable miniaturized, highly parallel and cost-effective 
approaches which could significantly improve the throughput 
of microbiological experiments such as described here.
4. Experimental Section
Chip Design and Fabrication: The chip consisted of two parts, the 
structured geometry (76 × 26  mm, 2.5  mm thick) and a flat cover 
(76 × 26 mm, 0.75 mm thick). The chip’s geometry as well as the cover 
were first designed using the computer aided-design (CAD) software 
Inventor Professional 2015 (Autodesk Inc., USA), then fabricated as a 
mold on an 8 mm-thick PMMA, (Evonik Industries) block using micro-
milling (Mini Mill GX, Minitech Machinery, US).[65] The milling program 
and code was constructed by the software Inventor HSM Pro (Autodesk 
Inc., USA). After milling, the PMMA molds were cleaned by pressurized 
air and washed with distilled water.
For casting the chip, the PDMS silicone elastomer was mixed with the 
curing agent (Sylgard 184, Down Corning) in a ratio of 10:1, respectively 
then degassed in vacuum chamber for 1 h. Afterward, the PDMS was 
poured into the PMMA mold and cured at 70 °C for 1 h. The solid PDMS 
structure and cover were peeled off the molds and treated by plasma 
(Plasma Technology GmbH, Germany) facing with the structured side 
upward. Subsequently the structure and cover were bonded and then 
incubated at 100 °C for 30 min leading to the final chip. The chips were 
sterilized by autoclaving at 121 °C for 20 min and stored for further use.
Gradient Validation: Utilizing the chip’s CAD geometry, the flow 
simulation was performed using the software COMSOL Multiphysics 
(version 5.2.1.152, COMSOL, Inc., USA) with the parameters stated 
in Figure  3a and Figure S3, Supporting Information. To retrieve a 
quantitative data from the simulated gradient, concentrations at five 
different points in every well were averaged as represented in Figure 3c. 
For the experimental validation, a stock solution of 40  mg L−1 xylene 
cyanol FF (XC, Sigma Aldrich Inc., Germany) in ddH2O was used to fill 
five 20  mL syringes (B. Braun Melsungen AG, Germany) as co-flows 
source. One 100 mL syringe (JMS Co. Ltd., Japan) filled of ddH2O was 
used as a main-flow source. The end concentrations in the wells were 
calculated from the solutions mixing equation (Equation (1)).
/m m c c m cC F C F C F Fx ) )( (= + +  (1)
Equation (1): Concentration mixing equation for setting or predicting 
the gradient profile in the chip. Cx: end concentration in a well X. Cm, 
Fm: concentration and flow rate (in µL min−1) of the advent main-flow, 
respectively. Cc, Fc: concentration and flow rate (in µL min−1) of the 
advent co-flow, respectively.
Main- and co-flow syringes were then installed in two independent 
syringe pumps (Nexus 3000, Chemyx Inc., USA). To deliver these fluids 
into the chip, syringes were connected to the chip through silicon tubes 
(Compagnie de Saint-Gobain, France) with an inner diameter of 1.6 mm, 
each tube was connected to a cannula of 0.8  mm outer diameter 
(B. Braun Melsungen AG, Germany) to be mounted into the chip. After 
installing all the fluidic connections, pumps were started infusing a 
main-flow of 10 µL min−1 water and co-flows of 2 µL min−1 XC into the 
chip as showed in Figure 3b. After running for 4 h at room temperature, 
the individual wells were sampled (15 µL) using a 1 mL syringe (B. Braun 
Melsungen AG, Germany) with a 0.45 mm cannula and their absorbance 
was analyzed in a Synergy H1 plate reader (BioTek Inc., USA) at 610 nm.
ALE on Chip: The lab model bacterium E. coli K12 sub-strain MG1655 
DSM 18 039 (DSMZ GmbH, Germany) harboring a kanamycin-selection 
plasmid (pMK-based backbone, lab stock) was used for all biological 
experiments. Luria–Bertani (LB) medium supplemented with 50 µg mL−1 
kanamycin was used for normal cultivation, stressor dilution, ALE 
experiments, and screening of E. coli at 37 °C, unless otherwise indicated. 
A monoclonal cryostock stored at −80 °C was used to inoculate 5 mL LB 
medium in 10 mL tube and incubated in 180 rpm shaker at 37 °C until 
its optical density at 600 nm (OD600) reached ≈1.0. The culture was then 
diluted with fresh LB to a final OD600 of 0.2, which had been used to 
inoculate the chip. The total sterile ALE setup is depicted in Figure S2, 
Supporting Information. Two main-flow syringes of 100 mL degassed LB 
(stress-free) were installed in a syringe pump, while 10 co-flow syringes 
of 20  mL degassed LB supplemented with the corresponding stressor 
antibiotic (rifampicin and nalidixic acid, PanReac AppliChem, Germany) 
were installed in a second syringe pump. The chips were connected 
to the corresponding syringes (each to a main 100 mL and five 20 mL 
co-flow syringes) through sterile tubes and cannulas as stated above, and 
the pumping was conducted for 1 h to stabilize the gradients. Afterward, 
the stress-free wells (0) were inoculated. Inoculation was conducted 
by injecting 10 µL culture into well 0 by piercing the chip from the side 
using a sharp needle (Ø 0.45 mm, B. Braun AG., Germany) connected to 
a 1 mL syringe. The media flow was stopped before inoculation to allow 
the cells to settle, and resumed again after 30 min from inoculation and 
continued until the termination of the experiment. To terminate the ALE 
experiment, the cannulas were disconnected from the chip, and its wells 
were sampled as stated above. 1 µL of each sample was diluted in 10 mL 
fresh LB, mixed well and plated on non-selective as well as selective 
LB-agar plates supplemented with respective antibiotics (100 µg mL−1 Rif 
and 40 µg mL−1 NA). Plates were then incubated at 37 °C for 24 h and 
the occurrence of adapted mutants was investigated visually.
Characterization of Mutants: Selected mutants from the selective 
antibiotic plates as well as the wild-type (WT) strain from non-selective 
plates were inoculated twice, one time into 5  mL of non-selective LB 
and the second into LB supplemented with the corresponding antibiotic 
and incubated overnight at 37 °C and 180 rpm. These pre-cultures of the 
mutants as well as the WT were then diluted with the same fresh media 
and cultivated in a 96-microtiter plate in a Synergy H1 plate reader, and 
their growth was recorded every hour for 24 h.
To analyze the mutants and WT genetically, the resistance-conferring 
genes were amplified by colony PCR using the primers listed in Table S1, 
Supporting Information. The correct size of the amplified DNA fragments 
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was confirmed by 0.8% agarose electrophoresis in 0.5 × TAE buffer. 
Successful PCRs were purified using the DNA Clean and Concentrator 
kit (Zymo Research Inc., Germany) following the manufacturer’s 
protocol and their sequences were verified (LGC genomics, Germany). 
The sequence data analysis and mutations localization were performed 
using the software Geneious 9.1.8 (Biomatters Ltd.).
Analysis of Biomass Composition: To analyze the composition of the 
biomass cultivated in the chip, E. coli was cultivated in two independent 
chips for 8 days under a continuous flow of LB-Kan using the same setup 
as described above (ALE on chip) except that the co-flows contained 
no stressor. Upon termination of the experiment, the chips were first 
evacuated from all biofilm-like material by pumping air through the main-
inlet and collecting the biomass at the outlet. The harvested BFL biomass 
was stained with a freshly prepared solution of 0.5% CV in ddH2O for 
25  min at room temperature. The remaining attached biomass was 
incubated in the chips at 70 °C for 45 min to fix the biofilm (BF) to the 
chip’s walls and channels. Subsequently, a freshly prepared solution 
of 0.5% crystal violet (CV) in ddH2O was pumped into the chips and 
incubated for 25  min at room temperature to stain the biomass. After 
incubation, the CV staining solution was removed from the chips, and 
the stained chips were washed with ddH2O and documented. Finally, 
the stained BF in the chips was dissolved with a solution of acetic acid 
33% v/v in ddH2O. To assess the BF and BFL dissolved CV content, 
samples were measured for their absorbance at 585 nm using Take3 plate 
in the reader Synergy H1 (both from BioTek Inc.). A chip containing only 
LB was treated with identical procedures as a negative control.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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